Assessing the Intestinal Microbiota in the SHINE Trial

Clin Infect Dis. 2015 Dec 15;61 Suppl 7(Suppl 7):S738-44. doi: 10.1093/cid/civ850.

Abstract

Advances in DNA sequencing technology now allow us to explore the dynamics and functions of the microbes that inhabit the human body, the microbiota. Recent studies involving experimental animal models suggest a role of the gut microbiota in growth. However, the specific changes in the human gut microbiota that contribute to growth remain unclear, and studies investigating the gut microbiota as a determinant of environmental enteric dysfunction (EED) and child stunting are lacking. In this article, we review the evidence for a link between the developing infant gut microbiota, infant feeding, EED, and stunting, and discuss the potential causal pathways relating these variables. We outline the analytic approaches we will use to investigate these relationships, by capitalizing on the longitudinal design and randomized interventions of the Sanitation Hygiene Infant Nutrition Efficacy trial in Zimbabwe.

Keywords: environmental enteric dysfunction; infant; microbiota; stunting.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diet
  • Female
  • Gastrointestinal Microbiome / genetics
  • Gastrointestinal Microbiome / physiology*
  • Growth Disorders / physiopathology*
  • Humans
  • Infant
  • Infant Nutritional Physiological Phenomena*
  • Intestines / microbiology
  • Intestines / physiopathology*
  • Male
  • Molecular Typing
  • Randomized Controlled Trials as Topic / methods
  • Research Design
  • Rural Population
  • Sequence Analysis, DNA
  • Zimbabwe